Want to see IMCR full AI Analyst Report?
Total Valuation
Immunocore Holdings has a market cap or net worth of $1.65B. The enterprise value is $1.43B.
Market Cap$1.65B
Enterprise Value$1.43B
Share Statistics
Immunocore Holdings has 50,865,574 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding50,865,574
Owned by Insiders0.04%
Owned by Institutions64.84%
Financial Efficiency
Immunocore Holdings’s return on equity (ROE) is -0.07 and return on invested capital (ROIC) is -4.10%.
Return on Equity (ROE)-0.07
Return on Assets (ROA)-0.02
Return on Invested Capital (ROIC)-4.10%
Return on Capital Employed (ROCE)-0.04
Revenue Per Employee603.59K
Profits Per Employee-53.59K
Employee Count493
Asset Turnover0.28
Inventory Turnover0.92
Valuation Ratios
The current PE Ratio of Immunocore Holdings is ―. Immunocore Holdings’s PEG ratio is 1.36.
PE Ratio―
PS Ratio5.87
PB Ratio4.59
Price to Fair Value4.59
Price to FCF-156.07
Price to Operating Cash Flow-65.11
PEG Ratio1.36
Income Statement
In the last 12 months, Immunocore Holdings had revenue of 297.57M and earned -26.42M in profits. Earnings per share was -0.53.
Revenue297.57M
Gross Profit291.36M
Operating Income-33.74M
Pretax Income-14.21M
Net Income-26.42M
EBITDA387.18K
Earnings Per Share (EPS)-0.53
Cash Flow
In the last 12 months, operating cash flow was -24.90M and capital expenditures -5.82M, giving a free cash flow of -30.72M billion.
Operating Cash Flow-24.90M
Free Cash Flow-30.72M
Free Cash Flow per Share-0.60
Dividends & Yields
Immunocore Holdings pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.71
52-Week Price Change-1.45%
50-Day Moving Average29.24
200-Day Moving Average32.52
Relative Strength Index (RSI)64.09
Average Volume (3m)394.33K
Important Dates
Immunocore Holdings upcoming earnings date is Aug 6, 2026, Before Open (Confirmed).
Last Earnings DateMay 6, 2026
Next Earnings DateAug 6, 2026
Ex-Dividend Date―
Financial Position
Immunocore Holdings as a current ratio of 4.04, with Debt / Equity ratio of 110.67%
Current Ratio4.04
Quick Ratio4.01
Debt to Market Cap0.23
Net Debt to EBITDA-80.12
Interest Coverage Ratio-2.77
Taxes
In the past 12 months, Immunocore Holdings has paid 12.21M in taxes.
Income Tax12.21M
Effective Tax Rate-0.86
Enterprise Valuation
Immunocore Holdings EV to EBITDA ratio is 4.43K, with an EV/FCF ratio of -153.30.
EV to Sales5.77
EV to EBITDA4.43K
EV to Free Cash Flow-153.30
EV to Operating Cash Flow-215.41
Balance Sheet
Immunocore Holdings has $844.90M in cash and marketable securities with $435.68M in debt, giving a net cash position of $409.21M billion.
Cash & Marketable Securities$844.90M
Total Debt$435.68M
Net Cash$409.21M
Net Cash Per Share$8.04
Tangible Book Value Per Share$7.57
Margins
Gross margin is 98.81%, with operating margin of -11.34%, and net profit margin of -8.88%.
Gross Margin98.81%
Operating Margin-11.34%
Pretax Margin-4.77%
Net Profit Margin-8.88%
EBITDA Margin0.13%
EBIT Margin-0.69%
Analyst Forecast
The average price target for Immunocore Holdings is $69.71, which is 11.43% higher than the current price. The consensus rating is Strong Buy
Price Target$69.71
Price Target Upside121.67% Upside
Analyst ConsensusStrong Buy
Analyst Count8
Revenue Growth Forecast23.64%
EPS Growth Forecast-29.23%